This is stated on the EMA website.

"To date, EMA has not received an application for a gradual examination or marketing authorization for the Sputnik V vaccine ... despite reports suggesting otherwise," the European regulator said in a statement.

Earlier it was reported that the Russian Direct Investment Fund (RDIF) filed an application for registration of the Sputnik V vaccine in the European Union on January 29, 2021 and launched the process of submitting information to the EMA through a gradual examination procedure.

On February 9 it became known that Sputnik V has passed the stage of scientific consultation of the European regulator.